These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36787498)
21. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes. Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438 [TBL] [Abstract][Full Text] [Related]
22. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. Zeng B; Gao L; Zhou Q; Yu K; Sun F BMC Med; 2022 May; 20(1):200. PubMed ID: 35606843 [TBL] [Abstract][Full Text] [Related]
24. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice. Natekar JP; Pathak H; Stone S; Kumari P; Sharma S; Auroni TT; Arora K; Rothan HA; Kumar M Viruses; 2022 May; 14(6):. PubMed ID: 35746611 [TBL] [Abstract][Full Text] [Related]
25. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants. Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B; Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242 [TBL] [Abstract][Full Text] [Related]
26. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach. Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134 [TBL] [Abstract][Full Text] [Related]
27. Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs. Wang B; Xu J; Wu S; Zhang Z; Zhao Z; Zhang J; Fu L; Zai X; Wang Y; Zhang G; Chen Z; Chen Y; Sun H; Song X; Zhang J; Zhu L; Hou L; Chen W Signal Transduct Target Ther; 2022 Jul; 7(1):257. PubMed ID: 35906201 [TBL] [Abstract][Full Text] [Related]
28. Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern. von Wintersdorff CJH; Dingemans J; van Alphen LB; Wolffs PFG; van der Veer BMJW; Hoebe CJPA; Savelkoul PHM Sci Rep; 2022 Aug; 12(1):13922. PubMed ID: 35978025 [TBL] [Abstract][Full Text] [Related]
29. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637 [TBL] [Abstract][Full Text] [Related]
30. Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines. Wang L; Kainulainen MH; Jiang N; Di H; Bonenfant G; Mills L; Currier M; Shrivastava-Ranjan P; Calderon BM; Sheth M; Mann BR; Hossain J; Lin X; Lester S; Pusch EA; Jones J; Cui D; Chatterjee P; Jenks MH; Morantz EK; Larson GP; Hatta M; Harcourt JL; Tamin A; Li Y; Tao Y; Zhao K; Lacek K; Burroughs A; Wang W; Wilson M; Wong T; Park SH; Tong S; Barnes JR; Tenforde MW; Self WH; Shapiro NI; Exline MC; Files DC; Gibbs KW; Hager DN; Patel M; Halpin AL; McMullan LK; Lee JS; Xia H; Xie X; Shi PY; Davis CT; Spiropoulou CF; Thornburg NJ; Oberste MS; Dugan VG; ; Wentworth DE; Zhou B Nat Commun; 2022 Jul; 13(1):4350. PubMed ID: 35896523 [TBL] [Abstract][Full Text] [Related]
31. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC). Tyagi N; Sardar R; Gupta D PeerJ; 2022; 10():e13562. PubMed ID: 35765592 [TBL] [Abstract][Full Text] [Related]
32. Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern. Svetlova J; Gustin D; Manuvera V; Shirokov D; Shokina V; Prusakov K; Aldarov K; Kharlampieva D; Matyushkina D; Bespyatykh J; Varizhuk A; Lazarev V; Vedekhina T Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362010 [TBL] [Abstract][Full Text] [Related]
33. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151 [TBL] [Abstract][Full Text] [Related]
34. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021. Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760 [TBL] [Abstract][Full Text] [Related]
35. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination. Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648 [TBL] [Abstract][Full Text] [Related]
36. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant. Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269 [TBL] [Abstract][Full Text] [Related]
37. Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. Dulovic A; Strengert M; Ramos GM; Becker M; Griesbaum J; Junker D; Lürken K; Beigel A; Wrenger E; Lonnemann G; Cossmann A; Stankov MV; Dopfer-Jablonka A; Kaiser PD; Traenkle B; Rothbauer U; Krause G; Schneiderhan-Marra N; Behrens GMN Emerg Infect Dis; 2022 Apr; 28(4):743-750. PubMed ID: 35203113 [TBL] [Abstract][Full Text] [Related]
38. Humoral immune response after different SARS-CoV-2 vaccination regimens. Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798 [TBL] [Abstract][Full Text] [Related]
39. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing. Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448 [TBL] [Abstract][Full Text] [Related]
40. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P; PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]